“…Although both lesions were clinically diagnosed as nodular BCC, each clinically showed a well-circumscribed, symmetrical lesion without ulceration, but neither the Although trichoblastoma is clearly a benign neoplasm of follicular germinative cells, and BCC is its malignant counterpart, the two are considered to represent different points along the same neoplastic spectrum based on the common molecular pathogenesis. [1][2][3] There are four types of lesions demonstrating the same neoplastic spectrum: (1) a lesion with almost equal histopathological components of both trichoblastoma and BCC and a clear border between the two components, 8,9,14 (2) trichoblastoma with a foci of BCC, 13 (3) BCC with a foci of trichoblastoma, 10,11,15,16 and (4) diagnostically confusing cases, whether trichoblastoma or BCC, with both features having no clear border between the two components. 12 There have been various attempts to differentiate trichoblastoma from BCC using immunohistochemical markers, including CD34-positive stromal cells or the staining pattern of bcl-2 in neoplastic aggregations.…”